Frequently Asked Questions
About GerMedCA
GerMedCA applies relevant German healthcare expertise and international best practices while adapting its work to each organisation’s local regulatory, operational and institutional context.
Is GerMedCA an official accreditation or regulatory body?
Who contracts and invoices GerMedCA services?
What is GENEXIX-cDT and how does it relate to GerMedCA?
No. GerMedCA is not a governmental, statutory or regulatory accreditation body. Its Quality Endorsement is a voluntary professional assessment and improvement framework based on selected German and international healthcare best practices.
GerMedCA is an initiative of Xcelenz GmbH, Karlsruhe, Germany. All commercial engagements and services offered under GerMedCA are contracted and invoiced by Xcelenz GmbH.
GENEXIX-cDT is a clinical digital twin and decision-support platform developed by Xcelenz GmbH. Within GerMedCA’s Technology Enablement offering, it may be considered alongside other suitable German and European healthcare technologies depending on institutional needs.
Can GerMedCA services be adapted to local healthcare systems?
What areas can GerMedCA support?
Does GerMedCA only offer Xcelenz technologies?
Yes. GerMedCA’s approach is designed to combine relevant German and international healthcare best practices with local regulations, infrastructure, workforce capabilities and institutional priorities.
GerMedCA works across four core areas: Hospital Quality Endorsement, Healthcare Consulting, Training & Capacity Building, and Technology Enablement & Digital Transformation.
No. GerMedCA’s Technology Enablement offering may include Xcelenz-developed technologies such as GENEXIX-cDT as well as suitable third-party healthcare technologies from the German and European market.
Have a question about GerMedCA?
Contact us if you would like to discuss GerMedCA’s services, quality endorsement approach, technology enablement or commercial engagement model.
